Remdesivir Maker Gilead Sciences Declares Dividend; Yield Is 3.9%
Although it isn't particularly famed as a dividend stock, Gilead Sciences (NASDAQ: GILD) is nevertheless a consistent payer of such distributions. Reinforcing this, the company -- these days considered a coronavirus stock due to its COVID-19 drug remdesivir -- has declared its latest quarterly dividend. On Friday's closing stock price, this would yield 3.9%.